Sana Biotechnology, Inc. (SANA) Total Return Calculator with Dividends Reinvested

Sana Biotechnology, Inc.

Popular:

The total return for Sana Biotechnology, Inc. (SANA) stock is +14.13% over the past 12 months. So far it's down 24.82% this year. The 5-year total return is -86.00%, meaning $10,000 invested in SANA stock 5 years ago would be worth $1,400 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in SANA 1 year ago, it would be worth $12,115 today — you'd have gained $2,115.

With Dividends Reinvested$12,115+21.15%

Price Only (No DRIP)$12,115+21.15%

Period2025-06-23 → 2026-06-18

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in SANA

1Y$11,413+$1,413 (+14.1%)14.1% CAGR

3Y$5,089-$4,911 (-49.1%)-20.2% CAGR

5Y$1,400-$8,600 (-86.0%)-32.5% CAGR

10Y$897-$9,103 (-91.0%)-21.4% CAGR

15Y$897-$9,103 (-91.0%)-14.8% CAGR

20Y$897-$9,103 (-91.0%)-11.4% CAGR

30Y$897-$9,103 (-91.0%)-7.7% CAGR

Sana Biotechnology, Inc. did not pay dividends during this period. Total return = price return.

Loading SANA total return...

As of 2026-06-21

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-24.82%	—	-24.82%	—	$7,518
1Y	+14.13%	14.13%	+14.13%	—	$11,413
3Y	-49.11%	-20.16%	-49.11%	—	$5,089
5Y	-86.00%	-32.51%	-86.00%	—	$1,400
10Y	-91.03%	-21.42%	-91.03%	—	$897
15Y	-91.03%	-14.85%	-91.03%	—	$897
20Y	-91.03%	-11.36%	-91.03%	—	$897
30Y	-91.03%	-7.72%	-91.03%	—	$897

Risk & Highlights

Best Year+146.67%2025

Worst Year-74.65%2022

Max Drawdown-54.73%2025-10-15 → 2026-03-30

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+0.48%	+0.48%	—	+0.41%	+0.1pp
2025	+146.67%	+146.67%	—	+16.64%	+130.0pp
2024	-61.19%	-61.19%	—	+24.00%	-85.2pp
2023	+9.38%	+9.38%	—	+24.81%	-15.4pp
2022	-74.65%	-74.65%	—	-19.95%	-54.7pp

SANA underperformed the S&P 500 by 10.86pp over the past year (+14.13% vs +24.99%).

Loading summary...

SANA Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
SANASana Biotechnology, Inc.	$877M	+3.6%	-24.8%	+14.1%	—	-49.1%	-86.0%	-91.0%
FATEFate Therapeutics, Inc.	$244M	+20.8%	+111.1%	+72.7%	—	-64.4%	-97.4%	+4.5%
CRSPCRISPR Therapeutics AG	$5.2B	+11.4%	+0.6%	+21.7%	—	-4.9%	-57.7%	+283.9%
BEAMBeam Therapeutics Inc.	$3.5B	+27.3%	+25.8%	+100.9%	—	+2.4%	-59.8%	+82.1%
EDITEditas Medicine, Inc.	$263M	+6.3%	+31.2%	+14.5%	—	-67.8%	-92.5%	-90.9%
NTLAIntellia Therapeutics, Inc.	$1.8B	+23.5%	+70.1%	+63.2%	—	-64.1%	-79.4%	-43.2%
ALNYAlnylam Pharmaceuticals, Inc.	$37.1B	-2.9%	-30.5%	-11.0%	—	+37.9%	+57.2%	+391.0%
IONSIonis Pharmaceuticals, Inc.	$12.2B	+2.2%	-7.0%	+100.3%	—	+80.5%	+96.1%	+221.7%
RCKTRocket Pharmaceuticals, Inc.	$366M	+9.1%	-3.2%	+18.4%	—	-85.2%	-92.2%	-89.0%
SGMOSangamo Therapeutics, Inc.	$75M	+41.1%	-59.1%	-63.3%	—	-84.9%	-98.4%	-96.9%
ILMNIllumina, Inc.	$24.6B	+14.4%	+20.5%	+79.4%	—	-17.6%	-63.5%	+18.9%

Compare:SANA vs FATE SANA vs CRSP SANA vs BEAM SANA vs FATE vs CRSP

About SANA Dividend Returns

Sana Biotechnology, Inc. (SANA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of SANA over the past year?

Sana Biotechnology, Inc. (SANA) delivered a return of 14.13% over the past year. Since SANA does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in SANA be worth today?

A $10,000 investment in Sana Biotechnology, Inc. one year ago would be worth $11,413 today, representing a gain of $1,413.

Q3Does SANA pay dividends?

Sana Biotechnology, Inc. (SANA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For SANA, the total return equals the price-only return.

Q4Did SANA beat the S&P 500?

No, Sana Biotechnology, Inc. (SANA) underperformed the S&P 500 by 10.86 percentage points over the past year. SANA delivered a total return of 14.13%, compared to the S&P 500's 24.99%. This means a passive S&P 500 index fund outperformed SANA by 10.86pp during this period.

Q5What is SANA's worst drawdown?

Sana Biotechnology, Inc. (SANA) experienced a maximum drawdown of -54.73% over the past year, declining from its peak on 2025-10-15 to its trough on 2026-03-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is SANA's long-term total return over 10, 20, or 30 years?

Here are Sana Biotechnology, Inc. (SANA)'s long-term returns with dividends reinvested. Over 10 years, the total return is -91.0% (-21.4% CAGR) — $10,000 would have grown to $897. Over 20 years: -91.0% total return (-11.4% CAGR) — $10,000 → $897. Over 30 years: -91.0% total return (-7.7% CAGR) — $10,000 → $897. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was SANA's best and worst year?

Sana Biotechnology, Inc.'s best calendar year was 2025 with a total return of 146.7%. Its worst year was 2022 with a total return of -74.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 221.3 percentage points.

How much would $100/month in SANA be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →